Results 301 to 310 of about 547,472 (401)

EM2, a Natural Product MST1/2 Kinase Activator, Suppresses Non‐Small Cell Lung Cancer via Hippo Pathway Activation

Advanced Science, EarlyView.
EM2 directly binds to and activates MST1/2, enhancing their kinase activity and sequentially promoting LATS phosphorylation, which increases YAP phosphorylation. Consequently, YAP nuclear translocation is suppressed, leading to reduced transcription of downstream targets CTGF and CYR61, ultimately exerting a robust inhibitory effect on NSCLC cell ...
Siyu Yang, Huayan Xie, Qiang Lin, Liujin Zhou, Junxi Liu, Zekai Fang, Ziling Tang, Ruijie Yuan, Jinxuan Su, Sijia Li, Wenlin Wang, Mingyu Pan, Hao Wang, Xiaoyong Dai, Guocai Wang, Yubo Zhang   +15 more
wiley   +1 more source

Different Subtypes of Human Lung Adenocarcinoma Caused by Different Etiological Factors [PDF]

, 2000
Takehisa Hashimoto, Yoshio Tokuchi, Moriaki Hayashi, Yasuhito Kobayashi, Kazunori Nishida, Shinichi Hayashi, Yuichi Ishikawa, Ken Nakagawa, Jun‐Ichi Hayashi, Eiju Tsuchiya   +9 more
openalex   +1 more source

Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study. [PDF]

EClinicalMedicine
Pu X, Lin G, Xiao M, Lin J, Wang Q, Kong Y, Yan X, Xu F, Xu Y, Li J, Li K, Chen B, Wen X, Tan Y, Cheng F, Zhu K, Li N, Wu L.   +17 more
europepmc   +1 more source

Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1

Advanced Science, EarlyView.
This study identifies transmembrane protein adipocyte‐associated 1 (TPRA1) as a novel receptor for oncolytic virus M1 (OVM). TPRA1's ectodomain binds OVM particles, while its intracellular domain facilitates virus internalization, promoting efficient viral entry.
Linyi Hu, Guigen Zhang, Yuan Lin, Shiming Yi, Jingyu Yang, Xueying Lin, Deli Song, Zhiheng Liu, Jiayu Zhang, Ying Zeng, Shanyu Huang, Zhen Fan, Jifu Zhang, Ying Liu, Cheng Hu, Wenbo Zhu, Wei Yin, Jun Hu, Guangmei Yan, Jing Cai, Jiankai Liang   +20 more
wiley   +1 more source

STAGE I ADENOCARCINOMA PRESENTING IN THE PNEUMONECTOMY SPECIMEN AT THE TIME OF SINGLE LUNG TRANSPLANTATION

, 1998
Charles A. Svendsen, Ross Bengtson, Soon J. Park, Sara J. Shumway   +3 more
openalex   +1 more source

Useful Prognostic Panel Markers to Express the Biological Tumor Status in Resected Lung Adenocarcinomas [PDF]

, 2000
Paulo Eduardo de Oliveira Carvalho
openalex   +1 more source

A Multifunctional Molecular Probe for Multimodal Imaging‐Guided Potent Photothermal/Photodynamic Therapy of Endometriosis

Advanced Science, EarlyView.
The cRGD‐ILD molecular probe integrates clinically available components: a cRGD peptide (integrin αvβ3 targeting), ICG (for fluorescence/photoacoustic imaging and phototherapy), and Gd‐DTPA (MRI contrast). Utilizing small size and receptor targeting, it achieves selective lesion accumulation.
Qiyu Zhong, Shuguang Yang, Xiao Li, Zhuang Jin, Jianyu Ma, Zhouzhou Liao, Jinbo Li, Bo Li, Xintao Shuai, Shuqin Chen   +9 more
wiley   +1 more source

Breast Carcinoma versus Lung Adenocarcinoma: The Immunohistochemical Discrimination of Breast Carcinoma Metastatic in Lung

, 1997
Claire B. Fabian, David J. Dabbs
openalex   +1 more source

Activity of growth factors in the IL-6 group in the differentiation of human lung adenocarcinoma [PDF]

, 2000
Carol McCormick, R. Ian Freshney
openalex   +1 more source

Biomarkers for Selection of Therapy for Adenocarcinoma of the Lung.

Journal of Oncology Practice, 2017
E. Bernicker, R. Miller, P. Cagle
semanticscholar   +1 more source